Updated Consensus Guidelines for Eosinophilic Esophagitis

Full text: ES Dellon, CA Liacouras,  J Molina-Infante, GT Furuta et al. Gastroenterol 2018; 155: 1022-33.

This article provides a thorough review of EoE -including clinical features, differential diagnosis, diagnostic criteria, and treatments.

Key point: “The evidence suggests that PPIs are better classified as a treatment for esophageal eosinophilia that may be due to EoE than as a diagnostic criterion, and we have developed updated consensus criteria for EoE that reflect this change.”

Related blog posts:

7 thoughts on “Updated Consensus Guidelines for Eosinophilic Esophagitis

  1. Pingback: Negligible Effect of Eosinophilic Esophagitis Treatment on Longitudinal Growth | gutsandgrowth

  2. Pingback: Promising Biologic for Eosinophilic Esophagitis | gutsandgrowth

  3. Pingback: What Happens When Topical Steroids Are Stopped in Eosinophilic Esophagitis | gutsandgrowth

  4. Pingback: Highest Reported Prevalence Rates for Eosinophilic Esophagits | gutsandgrowth

  5. Pingback: Orodispensable Budesonide Tablets for Eosinophilic Esophagitis | gutsandgrowth

  6. Pingback: Head-to-Head: Budesonide vs Fluticasone for Eosinophilic Esophagitis | gutsandgrowth

  7. Pingback: EoP –Biomarker or Balderdash? | gutsandgrowth

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.